The Federal Reserve raised interest rates by 25 basis points to a range of 3.75%-4%, marking its first hike since July 2023. Bitcoin remained stable near $76,000 despite the rate increase, showing resilience while US equities initially dipped but then rebounded, helped by falling oil prices. Fed Chair Kevin Warsh emphasized inflation remains high and hinted at a possible additional hike before year-end. Meanwhile, Bitcoin ETFs faced outflows and regulatory uncertainty increased after the Senate rejected the Clarity Act, signaling ongoing challenges for crypto investors.
Bitcoin's resilience near $76,000 comes as the Federal Reserve raised interest rates by 25 basis points to 3.75%-4%, its first hike since July 2023. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Sep 17, 2026 22:52 WIB: out of 50 major cryptocurrencies priced on Pluang, 46 rose and 3 fell today. Notable movers include AAVE up 8.26% at Rp2.227.598 with a typical hold time of 105 days and a Pluang order activity heavily skewed to selling at 96%, EOS up 8.13% at Rp12.649 with a typical hold time of 87 days, and BCH up 7.28% at Rp4.124.511 with a typical hold time of 68 days and a buy-side order activity of 78%.
Kering has released its monthly statement detailing the total number of shares and voting rights as of October 15, 2026. The company reported 123,420,778 total shares and 176,815,752 theoretical voting rights, with 176,046,302 exercisable voting righ...
Kering published its monthly update on October 15, 2026, reporting a total of 123,420,778 shares composing its capital and 176,815,752 theoretical voting rights. The voting rights figure includes all shares with voting rights, including those tempora...
Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...
Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...
